Fresenius Medical Care AG
XMUN:FME
Relative Value
The Relative Value of one
FME
stock under the Base Case scenario is
50.9
EUR.
Compared to the current market price of 39.38 EUR,
Fresenius Medical Care AG
is
Undervalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
FME Competitors Multiples
Fresenius Medical Care AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD | 0.2 | 54.7 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.3B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.4B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR | 1.2 | 20.9 | 9.8 | 14.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22B USD | 2 | 22.3 | 12.3 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.7 | 12 | 17.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.4 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.2B USD | 11.4 | -26.8 | -28.9 | -26.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.3 | 9.8 | |
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
10.5B AUD | 1 | 19.4 | 15.4 | 15.4 |